Abstract
Structural modification of a compound discovered during screening using an HRE-dependent reporter assay has revealed a novel class of HIF-1 inhibitors, which potently inhibit the HIF-1α protein accumulation and its target gene expression under hypoxic conditions in human hepatocellular carcinoma Hep3B cells.
Original language | English |
---|---|
Pages (from-to) | 1675-1684 |
Number of pages | 10 |
Journal | Journal of Medicinal Chemistry |
Volume | 50 |
Issue number | 7 |
DOIs | |
State | Published - 5 Apr 2007 |